|
Symbol
|
RMA0EV | RMA72V | RMBM8V | RMASDV | ABWQSQ | CHLBKB | ABITTQ | RMBQ3V | RMBQ5V | PEYRCH | CGJBKB | PGJRCH | RMBHUV | ABJTTQ | ABNSTQ | RMBRSV | RMA7JV | ABOMTQ | RMBAIV | PKRRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible |
|
Basiswert
|
Novo Nordisk AS (B) / Ypsomed Hldg. AG | Novartis AG / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Galderma Group AG / Givaudan / Ypsomed Hldg. AG | Roche PS / Sonova Hldg. AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Helvetia Baloise Holding AG / Ypsomed Hldg. AG / Sandoz Group AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Bachem Hldg. AG / Sandoz Group AG / Ypsomed Hldg. AG | Nestlé S.A. / Novartis AG / Roche PS / Ypsomed Hldg. AG | Sonova Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Alcon / Roche PS / Siegfried Hldg. AG / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | DOCMORRIS AG / Roche PS / Ypsomed Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Ypsomed Hldg. AG | Sonova Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Alcon / Lonza Group N / Ypsomed Hldg. AG |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
15.06.2026 | 31.08.2026 | 27.04.2026 | 11.05.2026 | 08.05.2026 | 11.05.2026 | 06.05.2026 | 18.05.2026 | 17.11.2026 | 18.05.2026 | 05.05.2026 | 22.05.2026 | 01.06.2026 | 12.05.2026 | 26.05.2026 | 22.05.2026 | 21.12.2026 | 03.06.2026 | 30.12.2026 | 30.06.2026 |
| Geld | 25.700 | 73.60 | - | 69.10 | 60.50 | 102.06 | 76.34 | 97.50 | 39.500 | 73.17 | 101.42 | 60.83 | 72.50 | 73.57 | 82.04 | 41.000 | 94.20 | 64.12 | 46.900 | 98.65 |
| Brief | - | - | - | - | - | 102.88 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |